ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19

Mostrar otras versiones (1)

Patients who died from COVID-19 often had comorbidities, such as hypertension, diabetes, and chronic obstructive lung disease. Although angiotensin-converting enzyme 2 (ACE2) is crucial for SARS-CoV2 to bind and enter host cells, no study has systematically assessed the ACE2 expression in the lungs...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Bruna G G, Oliveira, Antonio E R, Singh, Youvika, Jimenez, Leandro, Gonçalves, Andre N A, Ogava, Rodrigo L T, Creighton, Rachel, Peron, Jean Pierre Schatzmann, Nakaya, Helder I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377288/
https://www.ncbi.nlm.nih.gov/pubmed/32526012
http://dx.doi.org/10.1093/infdis/jiaa332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377288/
https://www.ncbi.nlm.nih.gov/pubmed/32526012
http://dx.doi.org/10.1093/infdis/jiaa332

Ejemplares similares